Concepedia

Donna Stock-Novack

DS

Statistics

Publications

10

Citations

890

H-Index

10

Active since

1987

Affiliations

University of Arizona(Current)

SWOG Cancer Research Network

University of Arizona Cancer Center

The University of Texas Medical Branch at Galveston

Fred Hutch Cancer Center

Donna Stock-Novack is an author at University of Arizona specializing in medicine, oncology, and heparins.

Top concepts

Publications per year

1987–2010

10

Publications

10

Improved therapeutic index of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide: final report by the Southwest Oncology Group of a phase III randomized trial in stages III and IV ovarian cancer.

David S. Alberts, S Green, Edward V. Hannigan et al. · Journal of Clinical Oncology · 1992 · 299 citations

Prognostic value of pretreatment serum beta 2 microglobulin in myeloma: a Southwest Oncology Group Study [see comments]

BG Durie, Donna Stock-Novack, SE Salmon et al. · Blood · 1990 · 163 citations · Full text

Prognostic value of pretreatment serum beta 2 microglobulin in myeloma: a Southwest Oncology Group Study [see comments]

BG Durie, Donna Stock-Novack, SE Salmon et al. · Blood · 1990 · 147 citations

Phase II randomized trial of cisplatin chemotherapy regimens in the treatment of recurrent or metastatic squamous cell cancer of the cervix: a Southwest Oncology Group Study.

David S. Alberts, Richard A. Kronmal, Lawrence Baker et al. · Journal of Clinical Oncology · 1987 · 80 citations

, , +16

Analysis of patient age as an independent prognostic factor for survival in a phase III study of cisplatin-cyclophosphamide versus carboplatin-cyclophosphamide in stages III (suboptimal) and IV ovarian cancer: A southwest oncology group study

David S. Alberts, Steve Dahlberg, Stephanie Green et al. · Cancer · 2010 · 74 citations

1–5 of 10